Product
Vonoprazan-based triple therapy
1 clinical trial
1 indication
Indication
Helicobacter pyloriClinical trial
Seven-Day Vonoprazan-Based Triple Therapy With High-Dose Amoxicillin as First-Line Helicobacter Pylori Treatment in Comparison With Extended Sequential Therapy: A Randomized Controlled Trial in TaiwanStatus: Active (not recruiting), Estimated PCD: 2023-12-30